In season 2, episode 8 of Targeted Talks, Jeff Yorio, MD, and Douglas Johnson, MD, MSCI, joins us for a talk around recent advances in immunotherapy for melanoma.

S2 Ep7: Recent Developments in Immunotherapy for Melanoma

<div>Targeted Oncology brings you <em>Treating Together</em>, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.</div>

Science

Health & Fitness

Targeted Oncology brings you Treating Together, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Targeted Oncology brings you <em>Treating Together</em>, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Share S2 Ep7: Recent Developments in Immunotherapy for Melanoma

Sign up to save your podcasts

S2 Ep7: Recent Developments in Immunotherapy for Melanoma

S2 Ep7: Recent Developments in Immunotherapy for Melanoma

More shows like Treating Together

Planet Money

Interesting Times with Ross Douthat